Abivax SA (Euronext Paris & Nasdaq: ABVX) (“Abivax” or the “Company”) held its ordinary and extraordinary general meeting of shareholders on May 30, 2024 (the “General Meeting”), which was chaired by Mr. Marc de Garidel, CEO and Chairman of the Board of Directors of Abivax (“Board”).
June 4, 2024
· 4 min read
